Page 2 - டோம் கவனக்குக்ஹ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டோம் கவனக்குக்ஹ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டோம் கவனக்குக்ஹ் Today - Breaking & Trending Today

Janssen's Innovation Strategy To Target Immune-Mediated Disease


Janssen s Innovation Strategy To Target Immune-Mediated Disease
By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical
Tom Cavanaugh believes there is a tremendous unmet need in the industry for treatments that target patients suffering from immune-mediated diseases. Cavanaugh, the president of immunology for Janssen in the U.S., notes that unmet need is a primary factor that drives the work he and his team perform. However, he believes there is good news for patients as well.
“There is a burgeoning base of new science that I believe will soon bring relief to those patients,” he says. “Despite the unmet need, there have been advances in this therapeutic area. Janssen is investing significantly into R&D to usher in a new era of treatment for those patients and others across all of the disease areas we address across the pharmaceutical companies of Johnson & Johnson.” ....

Tom Cavanaugh , Ed Miseta , Chief Editor , Momenta Pharmaceuticals , Wholistic View , டோம் கவனக்குக்ஹ் , தலைமை ஆசிரியர் , முழுமையான பார்வை ,

NOW, NOW, NOW... is Part of the Virtual Pittsburgh Fringe Festival


Award-winning Writer, Director, Producer Tom Cavanaugh brings his creation to the PITTSBURGH VIRTUAL FRINGE FESTIVAL along with a cast of nineteen actors in a bi-coastal, simulcast, multimedia event. Cavanaugh combines pre-recorded videos and music with live performances from actors from their Covid 19 safe homes! Using ZOOM as the medium, a safe haven for performers and audience members from the deadly virus has been created.
The Pittsburgh Fringe is an all-out, no-holds-barred, inclusive multi-disciplinary performing arts festival featuring international, national, and local artists. The annual festival will be in multiple venues in Pittsburgh s East End from Bloomfield and Friendship to Garfield and East Liberty along Penn Avenue. The festival will showcase theater (physical, street, musical), comedy, visual arts, puppetry, family entertainment, music, dance, spoken word, opera, poetry, literature, and shows we haven t even thought of yet! ....

United States , East Liberty , New Jersey , Tom Cavanaugh , Los Angeles , The Field , American Playwrights Program Utah Shakespearean Festival , Actors Studio Drama School , American Playwrights Program At Utah Shakespearean Festival , Dramatist Guild , National Playwrights Symposium At Cape May , Award Winning Writer , Producer Tom Cavanaugh , Pittsburgh Fringe , East End , New American Playwrights Program , Utah Shakespearean Festival , Mckinney Repertory Play Competition , House Roar Prize , Lionheart Theater , World Premiered , Lounge Theatre , Sweet Play Festival , Alternative Acts , Los Angele , Plays About Immigration ,

Janssen's Innovation Strategy To Target Immune-Mediated Disease


Janssen s Innovation Strategy To Target Immune-Mediated Disease
By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical
Tom Cavanaugh believes there is a tremendous unmet need in the industry for treatments that target patients suffering from immune-mediated diseases. Cavanaugh, the president of immunology for Janssen in the U.S., notes that unmet need is a primary factor that drives the work he and his team perform. However, he believes there is good news for patients as well.
“There is a burgeoning base of new science that I believe will soon bring relief to those patients,” he says. “Despite the unmet need, there have been advances in this therapeutic area. Janssen is investing significantly into R&D to usher in a new era of treatment for those patients and others across all of the disease areas we address across the pharmaceutical companies of Johnson & Johnson.” ....

Tom Cavanaugh , Ed Miseta , Chief Editor , Momenta Pharmaceuticals , Wholistic View , டோம் கவனக்குக்ஹ் , தலைமை ஆசிரியர் , முழுமையான பார்வை ,